A Randomized Trial Examining the Effectiveness of Switching From Olanzapine, Quetiapine, or Risperidone to Aripiprazole to Reduce Metabolic Risk: Comparison of Antipsychotics for Metabolic Problems (CAMP) -- Stroup et al., 10.1176/appi.ajp.2011.10111609 -
Links shared publicly online about this topic.
- 136total visits
A Randomized Trial Examining the Effectiveness of Switching From Olanzapine, Quetiapine, or Risperidone to Aripiprazole to Reduce Metabolic Risk: Comparison of Antipsychotics for Metabolic Problems (CAMP) -- Stroup et al., 10.1176/appi.ajp.2011.10111609 -
A Randomized Trial Examining the Effectiveness of Switching From Olanzapine, Quetiapine, or Risperidone to Aripiprazole to Reduce Metabolic Risk: Comparison of Antipsychotics for Metabolic Problems (CAMP) -- Stroup et al., 10.1176/appi.ajp.2011.10111609 -- Am J Psychiatry
View full resource at ajp.psychiatryonline.org
Tags: Bipolar Disorder Medication, Schizophrenia Medication, Antipsychotic Medication, Zyprexa, Risperdal, Seroquel, Psychiatry, Psychology
Most Recently Shared on July 19, 2011 at 6:01 am By:
AJP Psychiatry Journ A Randomized Trial Examining the Effectiveness of Switching From Olanzapine, Quetiapine, or... http://bit.ly/rgC759
Advertisement
